Zenghong Huang

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 4

Top Topics

Locally Advanced

Klebsiella Pneumoniae

Histone Deacetylase

Top Venues

OncoTargets and therapy

International journal of colorectal disease

Nature communications

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Zenghong Huang, Xiaolin Wang, Qi Zou, Zhuokai Zhuang, Yumo Xie, Du Cai, Liangliang Bai, Guannan Tang, Meijin Huang, Yanxin Luo, Huichuan Yu
High platelet-to-lymphocyte ratio predicts improved survival outcome for perioperative NSAID use in patients with rectal cancer. International journal of colorectal disease 35 (4) (2020)
Zhuojun Yu, Huichuan Yu, Qi Zou, Zenghong Huang, Xiaolin Wang, Guannan Tang, Liangliang Bai, Chuanhai Zhou, Zhuokai Zhuang, Yumo Xie, Heng Wang, Gaopo Xu, Zijian Chen, Xinhui Fu, Meijin Huang, Yanxin Luo
Nomograms for Prediction of Molecular Phenotypes in Colorectal Cancer. OncoTargets and therapy 13 (2020)
Yongqiang Wang, Zenghong Huang, Christopher Z Chen, Chengfei Liu, Christopher P Evans, Allen C Gao, Fangjian Zhou, Hong-Wu Chen
Therapeutic Targeting of MDR1 Expression by RORγ Antagonists Resensitizes Cross-Resistant CRPC to Taxane via Coordinated Induction of Cell Death Programs. Molecular cancer therapeutics 19 (2) (2019)
Demin Cai, Junjian Wang, Bei Gao, Jin Li, Feng Wu, June X Zou, Jianzhen Xu, Yuqian Jiang, Hongye Zou, Zenghong Huang, Alexander D Borowsky, Richard J Bold, Primo N Lara, Jian Jian Li, Xinbin Chen, Kit S Lam, Ka-Fai To, Hsing-Jien Kung, Oliver Fiehn, Ruqian Zhao, Ronald M Evans, Hong-Wu Chen
RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype. Nature communications 10 (1) (2019)